Navigation Links
Vaccine and antibiotics stabilized so refrigeration is not needed -- NIH study
Date:7/9/2012

rew also points out that the next step is to test it in the field.

Keeping medications cold from production until they are used in treatment is a costly process, accounting for as much as 80 percent of the price of vaccinations. The need for a cold chain has been a difficulty for health care providers, aid organizations, scientists and pharmaceutical companies for decades, especially in settings where electricity is limited. Failures in the chain result in the loss of nearly half of all global vaccines, according to researchers.

In an attempt to solve this problem, Kaplan and his lab have been working extensively with silk films that essentially wrap up the live bioactive molecules present in antibiotics and vaccines. This protects these essential bioactive elements, and so can greatly extend the shelf-life of the medication. Silk is used because it is a protein polymer with a chemistry, structure, and assembly that can generate a unique environment, making it an attractive candidate for the stabilization of bioactive molecules over extended periods of time.

To test their new silk stabilizers, Kaplan's team stored the measles, mumps, and rubella (MMR) vaccines for six months at the recommended 39.2 degrees Fahrenheit, as well as at 77, 98.6 , and 113 degrees Fahrenheit. The results show that encapsulation in the new silk films maintained the potency with minimal loss over time and enhanced stability, even at very high storage temperatures. Similarly, antibiotics entrapped in silk films maintained near optimal activity even at temperatures as high as 140 degrees. In addition, Kaplan's group found that these silk films had the added benefit of protecting one antibiotic against the detrimental effects of light exposure.

The silk stabilizers are likely to combine well with Kaplan's previously developed silk microneedle system. These tiny needles can deliver medication directly to skin cells that contain a specified antigen.
'/>"/>

Contact: Kate Egan
NIBIBPress@mail.nih.gov
301-451-0161
NIH/National Institute of Biomedical Imaging & Bioengineering
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Overweight? Theres a vaccine for that
2. Sensitive test helps improve vaccine safety
3. Army study: DNA vaccine and duck eggs protect against hantavirus disease
4. AAPS National Biotechnology Conference to highlight innovative vaccines
5. Researchers identify Achilles heel of dengue virus, target for future vaccines
6. SFU HIV/AIDS vaccine research gets financial boost
7. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
8. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
9. Queens scientists seek vaccine for Pseudomonas infection
10. Toward an alternative for antibiotics to fight bacterial infections?
11. The effect of treatment with antibiotics and vaccination against Q fever in sheep
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/wxdglm/global_wearable ... "Global Wearable Technologies Market and Applications, Opportunities, Industry ... Forecast 2014-2020" report to their offering. ... that can be worn on the user,s body ...
(Date:12/22/2014)... DUBLIN , Dec. 22, 2014 Research and ... the addition of the "The Global Watermarking ... http://photos.prnewswire.com/prnh/20130307/600769 ... global digital media watermarking and fingerprinting markets. Watermarking ...
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ...
Breaking Biology News(10 mins):Global Wearable Technologies Market and Applications, Opportunities, Industry Analysis, Segmentation, Size, Growth, Share, Overview, Trends and Forecast 2014-2020 2The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3
... History Survey have found that overall, concentrations of arsenic, selenium, ... Illinois River do not appear to be a health concern ... of the study have been published in the journal ... fillets was below the US Food and Drug Administration Action ...
... Hebrew university of Jerusalem have created a molecule that ... dementia or Alzheimer,s disease. Recent studies indicate that ... and non-diabetics are a risk factor for the development ... function. Diabetics have also been found to have twice ...
... in adulthood will be investigated as part of a major ... The 7.4 million programme, funded by the European Commission, ... eat and the types of food we choose. The ... eating habits develop and the influence of hunger, emotions, stress ...
Cached Biology News:Research shows arsenic, mercury and selenium in Asian carp not a health concern to most 2New molecule protects brain from detrimental effects linked to diabetes and high blood sugar 280 million SEK study seeks to explain what drives our appetites 2
(Date:1/22/2015)... Switzerland (PRWEB) January 22, 2015 Selexis ... characterized mammalian Research Cell Banks (RCBs) used for drug ... Research Cell Banks will include Next-Generation Sequencing ... genetic architecture de-risks biologic manufacturing by ensuring the integrity ...
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:1/22/2015)...  Derma Sciences, Inc. (Nasdaq: DSCI ), ... care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts ... the Premier, Inc. Regenerative Skin Grafting contract portfolio. ... and AMNIOMATRIX® product lines, which continue to be ...
(Date:12/24/2014)... , Dec. 24, 2014 PlasmaTech Biopharmaceuticals, Inc. (NASDAQ: ... areas, announced the closing of an underwritten public offering of ... to an aggregate 3,500,000 shares of common stock, at an ... The warrants have a per share exercise price of $5.00, ...
Breaking Biology Technology:Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3
... Community...promotes entertainment everywhere on any device , ,MADISON, ... the sale of the companys desktop products group for ... transaction is now complete and Sony Pictures Digitals Executive ... keep the companys employee base in Madison and in ...
... become leader in alternative energy , ,Madison, WI ... purchase agreement with two developers that will build three ... produced in Wisconsin by 400%. , ,Under the agreement, ... Midwest Wind Energy, LLC, based in Chicago, will provide ...
... Build it, and they will come is an acceptable strategy ... diamond in an Iowa cornfield, but its not normally the ... team of partners in place, the La Crosse Health Science ... transfer Field of Dreams. , ,The $27 million, 168,000-square-foot center ...
Cached Biology Technology:Sony Completes Acquisition of Sonic Foundry 2Sony Completes Acquisition of Sonic Foundry 3WE Energies Is Not Letting Wind Power Blow Away 2La Crosse Health Science Center is an Evolving Example of Collaboration 2La Crosse Health Science Center is an Evolving Example of Collaboration 3
... be used with all 96-well ... stacking of covered plates ... with automated systems ... are available for use with ...
... Two sizes available for use with 96- or 384-well ... 96 for ease of location on 96-tube plates ... the skirt of the plate* Efficient sealing is ... in conjunction with screw or clip-down hot lid thermal ...
... reagent is intended for use as a wash ... Michels Transport Fluid is useful for transportation of ... for immunofluorescence studies. Samples may remain in ... room temperature. Michels Transport Fluid is not ...
... HistoMark Biotin Streptavidin-HRP Systems provide rapid, ... intracellular antigens in frozen or paraffin-embedded ... These systems also facilitate double or ... be performed simultaneously with primary antibodies ...
Biology Products: